ASCO 2015 Highlights

Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Single-Agent Nivolumab in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Nivolumab Combined with Platinum-Based Doublet Chemotherapy in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Next-Generation TKIs

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Value-Based Use of Molecular and Genomic Markers

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

New Results with Existing Agents

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

New Molecular Targets for NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Immune Checkpoint Therapy in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Rechallenge with Anti-EGFR Therapy

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

BRAF + MEK Inhibitors in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Page 230 of 329